Page last updated: 2024-10-27

fluconazole and HIGM2 Syndrome

fluconazole has been researched along with HIGM2 Syndrome in 1 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Pacharn, P1
Phongsamart, W1
Boonyawat, B1
Jirapongsananuruk, O1
Visitsunthorn, N1
Chokephaibulkit, K1

Other Studies

1 other study available for fluconazole and HIGM2 Syndrome

ArticleYear
Disseminated cryptococcosis in two boys with novel mutation of CD40 Ligand-Associated X-linked hyper-IgM syndrome.
    Asian Pacific journal of allergy and immunology, 2021, Volume: 39, Issue:1

    Topics: Amphotericin B; Antifungal Agents; CD40 Ligand; Child; Cryptococcosis; Fluconazole; Humans; Hyper-Ig

2021